Rodríguez-Pérez María Dolores, López-Villodres Juan Antonio, Arrebola María Monsalud, Martín-Aurioles Esther, Fernández-Prior África, Bermúdez-Oria Alejandra, Ríos María Carmen, De La Cruz José Pedro, González-Correa José Antonio
Department of Pharmacology, Faculty of Medicine, Biomedical Research Institute (IBIMA), University of Malaga, 29010 Málaga, Spain.
Area of Human Histology, Faculty of Medicine, University of Malaga, 29010 Málaga, Spain.
Antioxidants (Basel). 2021 Nov 8;10(11):1783. doi: 10.3390/antiox10111783.
The aim of this study was to determine whether hydroxytyrosol administration prevented kidney damage in an experimental model of type 1 diabetes mellitus in rats. Hydroxytyrosol was administered to streptozotocin-diabetic rats: 1 and 5 mg/kg/day p.o. for two months. After hydroxytyrosol administration, proteinuria was significantly reduced (67-73%), calculated creatinine clearance was significantly increased (26-38%), and the glomerular volume and glomerulosclerosis index were decreased (20-30%). Hydroxytyrosol reduced oxidative and nitrosative stress variables and thromboxane metabolite production. Statistical correlations were found between biochemical and kidney function variables. Oral administration of 1 and 5 mg/kg/day of hydroxytyrosol produced an antioxidant and nephroprotective effect in an experimental model of type 1-like diabetes mellitus. The nephroprotective effect was significantly associated with the systemic and renal antioxidant action of hydroxytyrosol, which also influenced eicosanoid production.
本研究的目的是确定给予羟基酪醇是否能在大鼠1型糖尿病实验模型中预防肾脏损伤。将羟基酪醇给予链脲佐菌素诱导的糖尿病大鼠:口服剂量为1和5毫克/千克/天,持续两个月。给予羟基酪醇后,蛋白尿显著减少(67 - 73%),计算得出的肌酐清除率显著增加(26 - 38%),肾小球体积和肾小球硬化指数降低(20 - 30%)。羟基酪醇降低了氧化应激和亚硝化应激变量以及血栓素代谢产物的产生。在生化和肾功能变量之间发现了统计学相关性。在1型糖尿病样实验模型中,口服1和5毫克/千克/天的羟基酪醇产生了抗氧化和肾脏保护作用。肾脏保护作用与羟基酪醇的全身和肾脏抗氧化作用显著相关,这也影响了类花生酸的产生。